Motoharu Seiki

Active 1982–2024

148
Papers
31,752
Citations
104
h-index
148
i10-index

Citations

Citations per year for Motoharu Seiki1983: 7 citations1984: 62 citations1985: 91 citations1986: 98 citations1987: 104 citations1988: 179 citations1989: 141 citations1990: 161 citations1991: 173 citations1992: 176 citations1993: 127 citations1994: 139 citations1995: 208 citations1996: 312 citations1997: 368 citations1998: 453 citations1999: 528 citations2000: 483 citations2001: 492 citations2002: 492 citations2003: 601 citations2004: 499 citations2005: 366 citations2006: 445 citations2007: 348 citations2008: 272 citations2009: 255 citations2010: 259 citations2011: 196 citations2012: 180 citations2013: 164 citations2014: 157 citations2015: 144 citations2016: 105 citations2017: 173 citations2018: 74 citations2019: 378 citations2020: 321 citations2021: 337 citations2022: 253 citations2023: 176 citations2024: 190 citations2025: 111 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,690 citing papers, 32.9% of this breakdownJapan: 985 citing papers, 12.1% of this breakdownUnited Kingdom: 506 citing papers, 6.2% of this breakdownChina: 454 citing papers, 5.6% of this breakdownGermany: 432 citing papers, 5.3% of this breakdownFrance: 379 citing papers, 4.6% of this breakdownCanada: 282 citing papers, 3.5% of this breakdownItaly: 214 citing papers, 2.6% of this breakdownBelgium: 172 citing papers, 2.1% of this breakdownSpain: 167 citing papers, 2% of this breakdownSouth Korea: 150 citing papers, 1.8% of this breakdownAustralia: 148 citing papers, 1.8% of this breakdown
0%32.9%Other 19.5%

Fields

  • Biochemistry, Genetics and Molecular Biology51.9%
  • Medicine26.3%
  • Immunology and Microbiology16.2%
  • Neuroscience2.1%
  • Agricultural and Biological Sciences0.8%
  • Materials Science0.5%
  • Other2.2%

Topics

  • Protease and Inhibitor Mechanisms10.7%
  • Peptidase Inhibition and Analysis5.7%
  • Cell Adhesion Molecules Research4.8%
  • T-cell and Retrovirus Studies3.9%
  • Animal Disease Management and Epidemiology3.1%
  • Vector-Borne Animal Diseases3%
  • Other68.8%

Coauthors

All papers

Open in search
  1. Cortactin promotes exosome secretion by controlling branched actin dynamics

    Authors: , , , , , , , - The Journal of Cell Biology 2016 cited by 326

  2. MT1-MMP-Dependent Control of Skeletal Stem Cell Commitment via a β1-Integrin/YAP/TAZ Signaling Axis

    Authors: , , , , , , , , , , , , - Developmental Cell 2013 cited by 260

  3. A matrix metalloproteinase expressed on the surface of invasive tumour cells

    Authors: , , , , , , - Nature 1994 cited by 2,568

  4. The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis

    Authors: , , , , , , , , , , , , , , , , , , , - Cell 2001 cited by 715

  5. Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules

    Authors: , , , , , - Journal of Biological Chemistry 1997 cited by 936

  6. Turnover of Focal Adhesions and Cancer Cell Migration

    Authors: , , , , - International Journal of Cell Biology 2012 cited by 284

  7. Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration

    Authors: , , , , , , - The Journal of Cell Biology 2001 cited by 736

  8. Endothelial MT1‐MMP targeting limits intussusceptive angiogenesis and colitis via TSP1/nitric oxide axis

    Authors: , , , , , , , , , , , , - EMBO Molecular Medicine 2019 cited by 49

  9. MT1‐MMP: A potent modifier of pericellular microenvironment

    Authors: , - Journal of Cellular Physiology 2005 cited by 490

  10. Homophilic complex formation of MT1‐MMP facilitates proMMP‐2 activation on the cell surface and promotes tumor cell invasion

    Authors: , , , , , , , - The EMBO Journal 2001 cited by 394

  11. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein

    Authors: , , , , , , , , , , - mBio 2022 cited by 49

  12. EXOSC9 depletion attenuates P-body formation, stress resistance, and tumorigenicity of cancer cells

    Authors: , , , , , , , , , , , , , , - Scientific Reports 2020 cited by 31

  13. CD44 directs membrane‐type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin‐like domain

    Authors: , , , , , , , , - The EMBO Journal 2002 cited by 331

  14. Negative Regulation of Osteoclastogenesis by Ectodomain Shedding of Receptor Activator of NF-κB Ligand

    Authors: , , , , , , , , - Journal of Biological Chemistry 2006 cited by 232

  15. Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells

    Authors: , , , , , , , , , , , - Journal of Cell Science 2007 cited by 180

  16. Cell Surface Collagenolysis Requires Homodimerization of the Membrane-bound Collagenase MT1-MMP

    Authors: , , , , , - Molecular Biology of the Cell 2006 cited by 108

  17. Tetraspanin CD63 promotes targeting and lysosomal proteolysis of membrane-type 1 matrix metalloproteinase

    Authors: , , , , , - Biochemical and Biophysical Research Communications 2003 cited by 97

  18. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines.

    Authors: , , - Journal of Biological Chemistry 1993 cited by 291

  19. Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma

    Authors: , , , , , , - Cancer 2001 cited by 286

  20. Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers

    Authors: , , , , , , , , - Hepatology 1997 cited by 178

  21. Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis

    Authors: , , , , , , , , , , - Arthritis & Rheumatism 2009 cited by 134

  22. Transmembrane/cytoplasmic, rather than catalytic, domains of Mmp14 signal to MAPK activation and mammary branching morphogenesis via binding to integrin β1

    Authors: , , , , , , , , , , , - Development 2012 cited by 105

  23. Novel LAMC2 fusion protein has tumor‐promoting properties in ovarian carcinoma

    Authors: , , , , , , - Cancer Science 2021 cited by 25

  24. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease.

    Authors: , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1984 cited by 898